Movement Alert|CoreWeave, Inc. Falls 5.16% in Pre-Market Trading, Market Fears SpaceX Compute Expansion May Squeeze GPU Supply

Market Focus
Aug 06

On August 6, CoreWeave, Inc. declined 5.16% in pre-market trading, trading at $85.81/share, with turnover of $38.02 million.

On the news front, BNP Paribas analysts warned in their latest report that SpaceX's aggressive AI compute expansion plans could tighten GPU supply again, potentially squeezing chip allocation for CoreWeave despite its strategic partnership with NVIDIA. The analysts cautioned that if NVIDIA prioritizes its close collaboration with SpaceX, even strategic partners like CoreWeave may face reduced GPU allocations, raising concerns about the company's future compute supply security.

Adding to the pressure, Citi recently lowered its price target on CoreWeave from $158 to $142, while insider filings revealed that CEO Michael Intrator plans to sell 200,000 shares valued at approximately $17.15 million, and Chief Development Officer Brannin McBee executed sales of roughly 134,000 shares at prices between $70.53 and $85.62. CoreWeave is scheduled to report Q2 earnings on August 11, with consensus expecting revenue growth of approximately 137% year-over-year.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10